Fibrinogen and Risk of Cardiovascular Disease: The Framingham Study

JAMA: The Journal of the American Medical Association

Volumn 258, Issue 9, 1987, Pages 1183-1186

  Kannel, William B ^a   Wolf, Philip A ^b   Castelli, William P ^c   D’agostino, Ralph B ^d  

^a Dept of Medicine   (United States)

^b Department of Neurology ^*  (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^d BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ADULT; AGED; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; METABOLISM; RISK; SEX DIFFERENCE; UNITED STATES;

AGED; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; FEMALE; FIBRINOGEN; HUMAN; LONGITUDINAL STUDIES; MALE; MASSACHUSETTS; MIDDLE AGE; RISK; SEX FACTORS; STATISTICS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023644095     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1987.03400090067035     Document Type: Article

References (25)

1. Duquid JB: Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. J Pathol Bacteriol 1946;58:207-212.
2. Dintenfass L, Julian DG, Miller G: Viscosity of blood in normal subjects and in patients suffering from coronary occlusion and arterial thrombosis. Am Heart J 1966;71:587.
3. Burch GE, Depasquale NP: Hematocrit, viscosity and coronary blood flow. Dis Chest 1965;48:225.
4. Meade TW, Chakrabarti R, Haines AP, et al.: Hemostatic function and cardiovascular death: Early results of a prospective study. Lancet 1980; 1:1050-1054.
5. Merrill EW: Rheology of blood. Physiol Rev 1969;49:863-887.
6. Swain WR, Feders MB: Fibrinogen assay. Clin Chem 1967;13:1026-1028.
7. Ratnoff OD, Menzie C: A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med 1951;37:316-320.
8. Gordon T, Moore FE, Shurtleff D, et al.: Some methodologic problems in the long term study of cardiovascular diseases: Observations from the Framingham Study. J Chronic Dis 1959;10: 186-206.
9. Shurtleff D: Some Characteristics Related to the Incidence of Cardiovascular Disease and Death: Framingham Study—18 Year Follow-up, Section 30, publication (NIH) 74-599. US Dept of Health, Education, and Welfare, 1984.
10. Walker SH, Duncan DB: Estimation of the probability of an event as a function of several independent variables. Biometrika 1967;54: 167-174.
11. Strong JP, Eggen DA, Oakmann MC: The natural history, geographic pathology and epidemiology of atherosclerosis, in Wissler RW, Geer JC (eds): The Pathogenesis of Atherosclerosis. Baltimore, Williams & Wilkins, 1972, p 20.
12. Blumgart HL, Schlessinger MJ, Zoll PM: Angina pectoris, coronary failure and acute myocardial infarction role of coronary occlusions and collateral circulation. JAMA 1941;116:91.
13. DeWood MA, Spores J, Notske R, et al.: Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902.
14. Branwood AW, Montgomery GL: Observations on the morbid anatomy of coronary artery disease. Scott Med J 1956;1:367-375.
15. Ridolfi RL, Hutchins GM: The relationship between coronary artery lesions and myocardial infarcts: Ulceration of atherosclerotic plaques, precipitating coronary thrombosis. Am Heart J 1977; 93:468-486.
16. Oliva PB, Breckenridge JC: Arteriographic evidence of coronary arterial spasm in acute myocardial infarction. Circulation 1977;56:366-374.
17. Rentrop KP, Blanke H, Karsch KR, et al.: Acute myocardial infarction: Intracoronary application of nitroglycerine and streptokinase. Clin Cardiol 1979;2:354-363.
18. Gold HK, Leinbach AC: Coronary obstruction in anterior myocardial infarction: Thrombus or spasm? Am J Cardiol 1980;45:483.
19. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, et al.: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-505.
20. Korsan-Bengtsen K, Wilhelmsen L, Tibblin G: Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old: II. Relations of the variables to ’risk factors’ for myocardial infarction. Thromb Diathes Haemorrh 1972;28:99-108.
21. Meade TW, Chakrabarti R, Haines AP, et al.: Characteristics affecting fibrinolytic activity and plasma fibrinogen concentration. Br Med J 1979;1: 153-156.
22. Mershey C. Wohl H: Changes in blood coagulation and fibrinolysis in rats fed atherogenic diets. Thromb Diathes Haemorrh 1964;10:295.
23. Lowe GDO, Drummond MM, Third JLH, et al.: Increased plasma fibrinogen and platelet aggregates in type II hyperlipoproteinemia. Thromb Haemost 1979;42:1503-1507.
24. Lowe GDO, Morrice JJ, Forbes CD, et al.: Subcutaneous ancrod therapy in peripheral arterial disease: Improvement in blood viscosity and nutritional flow. Angiology 1979;30:594-599.
25. Smith ED, Staples EM, Dietz HS, et al.: Role of endothelium in sequestration of lipoprotein and fibrinogen in aortic lesions, thrombi and graft pseudointimas. Lancet 1979;2:812-816.